Samit Bhattacharya is a seasoned medicinal chemist with over 20 years of extensive experience in drug discovery, currently serving as an Associate Research Fellow at Pfizer. His expertise spans multiple therapeutic areas, with a significant focus on Oncology and Diabetes. Throughout his career, Samit has...
Samit Bhattacharya is a seasoned medicinal chemist with over 20 years of extensive experience in drug discovery, currently serving as an Associate Research Fellow at Pfizer. His expertise spans multiple therapeutic areas, with a significant focus on Oncology and Diabetes. Throughout his career, Samit has demonstrated a remarkable ability to lead and collaborate within multi-disciplinary teams, successfully advancing numerous clinical candidates to human clinical trials. His work in the Diabetes therapeutic area is particularly noteworthy; he has played a pivotal role in advancing a GPCR modulator candidate that is currently undergoing clinical trials. This project not only showcases his proficiency in drug development but also highlights his commitment to addressing unmet medical needs in diabetes management.
In addition to his work on diabetes, Samit is actively involved in early exploratory projects within Cardiovascular and Metabolic Diseases (CVMED), where he utilizes his skills in high-throughput screening (HTS) and hit follow-up strategies to identify promising drug candidates. His contributions to oncology are equally impressive, having led multiple kinase inhibitor projects that have resulted in several clinical candidates, further solidifying his reputation as a leader in the field.
Samit's technical skills encompass a wide range of disciplines, including drug metabolism, ADME (Absorption, Distribution, Metabolism, and Excretion), and synthetic organic chemistry. His deep understanding of pharmacology and drug disposition, combined with his leadership experience in non-profit initiatives, positions him as a valuable asset in the pharmaceutical landscape. As he continues to push the boundaries of drug discovery at Pfizer, Samit remains dedicated to translating scientific innovation into tangible therapeutic solutions that improve patient outcomes.
